Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Diabetes|February 1, 1975
Inordinately high levels of serum immunoreactive insulin in monoclonal immunoglobulinemia (on the problem of "big, big insulin")J Sramkova, J Pav, O Engelberth
The Journal of Trauma|November 1, 1985
Carburetor priming: a cause of gasoline burnM Klabacha, H Nelson, P Parshley, et al.
Computer Methods and Programs in Biomedicine|January 1, 1994
Risk calculation of type 2 diabetesT Haas, S Svacina, J Pav, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
Disposition and biotransformation of the antiretroviral drug nevirapine in humansP Riska, M Lamson, T MacGregor, et al.
Cancer|June 1, 1989
The United States experience with oral controlled-release morphine (MS Contin tablets). Parts I and II. Review of nine dose titration studies and clinical pharmacology of 15-mg, 30-mg, 60-mg, and 100-mg tablet strengths in normal subjectsR F Kaiko, R P Grandy, B Oshlack, et al.
Journal of Thrombosis and Haemostasis : JTH|February 18, 2017
A first-in-human study of DS-1040, an inhibitor of the activated form of thrombin-activatable fibrinolysis inhibitor, in healthy subjectsJ Zhou, J Kochan, O Yin, et al.
Science Advances|September 16, 2020
Targeted disruption of Kv2.1-VAPA association provides neuroprotection against ischemic stroke in mice by declustering Kv2.1 channelsAnthony J Schulien, Chung-Yang Yeh, Bailey N Orange, et al.
The Journal of Infectious Diseases|August 11, 1998
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 TeamM Mirochnick, T Fenton, P Gagnier, et al.
Pageof 1